Life sciences organizations are entering a new phase where scientific, technical, and regulatory forces are converging. As teams prepare for the next wave of transformation, 2026 is poised to bring meaningful shifts in how discovery, development, and clinical groups design studies, generate insights, and operationalize advanced analytics at scale. Join Domino Data Lab and AstraZeneca for a forward-looking discussion on the emerging trends that will shape the year ahead and what leaders can do now to position their teams for impact across both AI and modern data science practices.

Why join

• Hear AstraZeneca’s perspective on the trends that will matter most for data science and AI across R&D, clinical development, and digital transformation in 2026
• Get practical guidance on how data science and IT teams can prepare for rising expectations around model governance, analytical rigor, and operational readiness
• Learn how peers are planning for 2026 and what capabilities in data management, scientific computing, and AI-enabled workflows will differentiate organizations entering the next stage of life sciences innovation

Speakers

• Jamie O’Keefe, Head, Development and Regulatory Data, Digital & Technolody, Takeda
• Tiffany Fabianac, Director – FAIRR Analytics, Oncology Data Science & AI, AstraZeneca
• Chris McSpiritt, VP of Life Sciences Strategy, Domino Data Lab

Join the Horizon Europe Health info day to learn more about the 2026 topics of the forthcoming Work Programme 2026-2027.

The following events are missing "Event Type"

About the AHRQ Safety Program for HAI Prevention

The Agency for Healthcare Research and Quality (AHRQ), in conjunction with NORC at the University of Chicago and the Johns Hopkins University, created the AHRQ Safety Program for Healthcare-Associated Infection (HAI) Prevention to implement a bundle of recently updated evidence-based infection prevention toolkits designed to measurably decrease HAIs in intensive care units (ICUs) and non-ICUs across the United States. The AHRQ Safety Program for HAI Prevention builds on AHRQ’s pioneering work using Comprehensive Unit-based Safety Program (CUSP) methods to reduce three common HAIs: central line-associated bloodstream infections, catheter-associated urinary tract infections, and ventilator-associated pneumonia and ventilator-associated events. This program aims to refine the current AHRQ toolkits for preventing these HAIs to ensure they meet the needs of our current healthcare environment.

HAIs are a major cause of illness in the United States, affecting about 3 percent of all hospitalized patients and resulting in as many as 700,000 infections per year.[1] HAI prevention efforts are challenged by (1) the COVID-19 pandemic, (2) the need for updated evidence and toolkits, and (3) antimicrobial resistance. The program aims to enhance the utility of existing HAI prevention toolkits by updating them with the latest evidence and refining them using lessons learned from their real-world implementation.

[1] Centers for Disease Control and Prevention. HAIs: Reports and Data. Updated November 25, 2024. Accessed October 2024. HAIs: Reports and Data | HAIs | CDC.

The global collaborative network for leading pharma innovators

One foundation. Cross-functional strength. Elevated impact.

For years, the question was: What do we build next? More sophisticated AI. More advanced engagement models. Wider access strategies. Each impressive. Each reaching higher.

Then market winds shifted. New regulations arrived. Suddenly, the question changed: Can our foundations hold?

Walls between functions preventing flexibility. Disconnected data infrastructure fragmenting insights. Inefficiencies becoming liabilities under pressure.

Those walls aren't load-bearing, they're removable. That data infrastructure can reinforce decisions. And patient purpose? That's the force binding everything together.

You must underpin your customer engagement strategy with reimagined data and infrastructure. You must reprioritise your launch plans to deliver value across patient priorities. Four separate pillars that become one reinforced foundation.

Join us in Barcelona. The annual inflection point where we practice what we preach. 2026 brings you a reimagined experience, with the entire event rebuilt in 1 room that includes all 1,200 attendees, 4 cross-functional streams, interactive workshops and experiences.

Come build the foundations for the future.

Download your copy of the Brochure

Speakers:

- Mark Blaskovich, Director of Translation for the Institute for Molecular Bioscience, University of Queensland (Australia)
- Matthew Todd, Chair of Drug Discovery, University College London (UK)
- Luiza Galarion, Research Fellow, University of Leeds (UK)

Moderated by Heike Brötz-Oesterhelt, Professor of Microbiology, Dept. of Microbial Bioactive Compounds, University of Tübingen (Germany)

• Presentation 1: Scientific Bottlenecks in Antibiotic Discovery (Mark Blaskovich)
• Presentation 2: Leveraging Shared Data to Strengthen Discovery (Matthew Todd)
• Presentation 3: AntibioticDB: A Tool for Smarter Discovery (Luiza Galarion)

This live webinar including an interactive Q&A session will be broadcast on 27 November 2025 at 10:00-11:30 CET // 09:00-10:30 GMT. Find your timezone here: https://www.timeanddate.com/worldclock/converter.html?iso=20251127T090000&p1=87&p2=136&p3=47

If you have questions or comments, please let us know: This email address is being protected from spambots. You need JavaScript enabled to view it..

This webinar was dedicated to the healthcare and pharmaceutical industries, exploring the transformative impact of AI in these sectors.

This session was the first of a series of Apply AI thematic webinars, focusing on a cluster of strategic sectors to explore practical applications, use cases, and the specific needs of the industries.

Moderator

Nathalie Vandystadt, Coordinator for Stakeholder Communication and Outreach, AI Office

Speakers

Malgorzata Nikowska, Head of Unit AI Innovation and Policy Coordination, AI Office.
Saila Rinne, Head of Unit Artificial Intelligence in Health and Life Sciences, AI Office.
Fulvia Raffaeli, Head of Unit Digital Health, DG SANTE

Topics

Health and pharmaceuticals as key sectors in the Apply AI Strategy
How the Apply AI Strategy strengthens or complements the initiatives already in place
AI Apply Strategy’s impact on patients and healthcare systems

Background

Presented by the Commission on 8 October 2025, the Apply AI Strategy considers healthcare and pharmaceutical industries among its 12 key sectors. The strategy will foster an AI first policy where AI is considered as a potential solution whenever organisations make strategic or policy decisions, taking into careful consideration the benefits and the risks of the technology. It aims to boost innovation, particularly among SMEs, and reinforce Europe's technological sovereignty by connecting world-class infrastructure, data, and testing facilities with the needs of key industrial sectors and the public sector.

Antimicrobial resistance (AMR) and sepsis remain urgent and interconnected global health threats. As part of World AMR Awareness Week, the Global Sepsis Alliance is partnering with Biotest, Menarini, and bioMérieux to host a three-part webinar series on AMR and sepsis. After opening the series with a session on diagnostic innovation and targeted therapy on November 20, we now turn to the next topic.

We are delighted to invite you to the World Sepsis Congress Satellite Session: AMR and Sepsis in Cancer Patients, scheduled for Monday, November 24, 2025, from 15:00 to 16:30 CET. This 90-minute online event explores the urgent challenges at the intersection of AMR, oncology, and sepsis, featuring leading experts, patient advocates, and frontline clinicians.

An educational grant from Menarini kindly supports this webinar.

Speakers include:

• Prof. Naoyuki Matsuda – Nagoya University Graduate School of Medicine & Board Member of the Global Sepsis Alliance, Japan

• Prof. Evangelos Giamarellos-Bourboulis – Kapodistrian University of Athens, Chair of the European Sepsis Alliance, Board Member of the Global Sepsis Alliance, Greece

• Prof. Djillali Annane – Raymond Poincaré Hospital, Steering Committee Member of the European Sepsis Alliance, France (prerecorded)

• Dr. Diego Lopez Mendoza – Intensive Care Specialist and Menarini Global Medical Lead - Anti-infectives, Spain

• Dr. Nveed Chaudhary – Founder of The Jibraan Chaudhary Sepsis Research Foundation

• Ilse Malfait – Cancer and Sepsis Survivor, Sepsibel

This session will be moderated by Dr. Mariam Jashi, CEO of the GSA Global Sepsis Alliance.

About the Session

Cancer patients, particularly those who are immunocompromised, face a heightened risk of severe infections and sepsis, while AMR increasingly limits effective treatment options. This session will provide an overview of:

• Key links between cancer and sepsis
• Sepsis in immunocompromised patients
• Managing resistant infections in oncology
• Patient and family perspectives

Why Join?

The session offers valuable insights for anyone working in or interested in AMR, cancer care, infectious diseases, sepsis management, or patient advocacy.

Orientering om & nye erfaringer fra arbejdet med kliniske retningslinjer i samarbejde med Sundhedsvæsenets Kvalitetsinstitut

De Lægevidenskabelige Selskaber, Lægeforeningen og Sundhedsvæsenets Kvalitetsinstitut indkalder alle interesserede til fyraftensmøde med fokus på den styrkede indsats vedr. kliniske retningslinjer i LVS-regi.
Mødet afvikles to gange, med mulighed for deltagelse enten i Aarhus eller København.
Mødet den 15. januar forventes desuden at kunne streames via Teams.
Inden mødet serveres sandwich & vand.

Program

Moderatorer: Camilla Noelle Rathcke & Susanne Axelsen

Session I

17.00-17.10 Velkomst, baggrund & formål med aftenen v/Susanne Axelsen, formand for LVS

17.10-17.20 Styrket indsats i SundK med kliniske retningslinjer, det metodiske udgangspunkt og status på retningslinjeplatform v/Henriette Lipczak, vicedirektør i SundK

17.20-17.30 Samarbejdet mellem LVS’erne, Lægeforeningen og Danske Regioner om kliniske retningslinjer v/Camilla Rathcke, formand for Lægeforeningen

17.30-17.40 Erfaringer fra DMCG’erne - tips & tricks til arbejdet i LVS-regi v/Camilla Qvortrup, formand for DMCG.dk

17.40-17.50 Fra erfaring til fælles retning; fordele & ulemper ved det nye set-up fra et erfaringstungt selskab v/Mette Hvilshøj, formand for Dansk Selskab for Gynækologi & Obstetrik

17.50-18.00 Fra kræft til benigne sygdomme – fordele & ulemper ved retningslinjer under udvikling i et nyt set-up v/Bettina Nørby, formand for Dansk Urologisk Selskabs koordinerende retningslinjeudvalg

Kort pause

Session II

18.15-18.25 Erfaringer fra Dansk Selskab for Geriatri - i fuld gang med nye retningslinjer 15/1 v/afventer og 25/2 v/Marie Sahlberg, medlem af Dansk Selskab for Geriatri

18.25-18.55 Q&A - drøftelse i plenum med alle oplægsholdere

Hvordan kan Retningslinjefunktionen konkret understøtte arbejdet i praksis?

Hvornår i retningslinjeprocessen er det mest relevant at involvere Retningslinjefunktionen?

Hvordan håndteres retningslinjer, der går på tværs af fagligheder og sektorer?

Hvordan sikrer vi forankring og effektiv vidensdeling om retningslinjearbejdet i hele selskabet?

18.55-19.00 Tak for i dag v/moderator

Save the date: 23–25 June 2026

(Day 1 hybrid from London & online; Days 2–3 fully online)

Organised by Health Care Without Harm (HCWH) Europe, CleanMed Europe brings together professionals from healthcare, sustainability, industry, research, and civil society each year to advance low-carbon, resilient, and sustainable health systems.

We are pleased to announce that CleanMed Europe 2026 will take place from 23–25 June 2026.

In 2026, HCWH Europe’s flagship conference will once again bring together everyone committed to building a sustainable and climate-resilient healthcare sector under the theme “​​Leading Healthcare Climate Action”.

23 June - Day 1

Hybrid from London, UK

For the first time, the opening day of CleanMed Europe (23 June) will take place as a hybrid event. You can join us online from wherever you are – or meet us in person in London, UK, during London Climate Action Week, a vibrant moment when the city becomes a hub for climate leadership and innovation.

24–25 June - Days 2 & 3

Online

On 24 and 25 June, CleanMed Europe continues fully online with two days of keynote presentations, interactive sessions, and workshops that will deepen learning and equip participants with practical tools, strategies, and examples that can be applied in their own organisations.